New Delhi, May 8 (PTI) The Initial Public Offer (IPO) of healthcare tech firm Indegene got subscribed 69.71 times on the closing day of bidding on Wednesday.

The Rs 1,841.75 crore IPO received bids for 2,01,22,03,281 shares against 2,88,66,677 shares on offer, as per NSE data.

Also Read | What Is West Nile Fever? As Cases Reported in Kerala, Know All About Symptoms, Causes and Treatment for West Nile Virus Infection.

The portion for Qualified Institutional Buyers (QIBs) got subscribed a whopping 197.55 times while the part for non-institutional investors received 54.75 times subscription. The quota for Retail Individual Investors (RIIs) garnered 7.68 times subscription.

The IPO had a fresh issue of up to Rs 760 crore and an offer for sale of up to 2,39,32,732 equity shares.

Also Read | NEET Exam 2024: NTA Holds NEET UG Undergraduate Medical Entrance Exam Today, Check Dress Code Guidelines, Reporting Time, List of Prohibited Items and Other Important Instructions.

The price range for the offer remained Rs 430-452 a share.

On Friday, Indegene Ltd said it raised Rs 549 crore from anchor investors.

Funds raised through the fresh issue would be used to pay debt, fund capital expenditure requirements, payment of deferred consideration for one of its past acquisitions, fund inorganic growth and general corporate purposes.

Founded in 1998, Indegene offers solutions that help enable biopharmaceutical, emerging biotech and medical devices companies to develop products, launch them in the market, and drive sales throughout their life cycle.

Kotak Mahindra Capital Company, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) are the managers to the offer.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)